US Broker Ratings

Bristol-Myers Squibb (BMY) Stock Analysis: Navigating Growth with Strong Dividends and Robust Product Pipeline

Bristol-Myers Squibb Company (NYSE: BMY) stands as a formidable entity within the healthcare sector, specifically in the realm of drug manufacturing. With a robust market capitalization of $133.41 billion, this..

McKesson Corporation (MCK) Stock Analysis: Exploring a Resilient Healthcare Giant with 10.62% Upside Potential

McKesson Corporation (NYSE: MCK), a stalwart in the medical distribution industry, commands significant attention as a leading player within the healthcare sector. With a robust market capitalization of $100.24 billion,..

Mettler-Toledo International (MTD) Stock Analysis: Navigating Potential in the Healthcare Sector

Mettler-Toledo International Inc. (NYSE: MTD), a prominent player in the Healthcare sector, stands as a global leader in precision instruments and services, catering to diverse industries from pharmaceuticals to logistics...

Edwards Lifesciences (EW) Stock Report: Healthcare Innovator with 17.3% Upside Potential

Edwards Lifesciences Corporation (NYSE: EW), a leading player in the healthcare sector, specializes in medical devices focused on treating advanced cardiovascular diseases. With its headquarters in Irvine, California, and a..

IQVIA Holdings, Inc. (IQV): Investor Outlook with 16% Upside Potential

IQVIA Holdings, Inc. (NYSE: IQV), a leader in the healthcare sector, is grabbing investor attention with its promising potential upside of 16.14%. As a key player in the diagnostics and..

CVS Health Corporation (CVS) Stock Analysis: Navigating Growth in the Healthcare Sector with a Potential Upside

CVS Health Corporation (NYSE: CVS) stands as a formidable player in the healthcare sector, boasting a market cap of $133.25 billion. Operating primarily within the healthcare plans industry, CVS has..

Natera, Inc. (NTRA) Stock Analysis: Navigating Growth in the Diagnostics Sector Amid a 38.80% Revenue Surge

Natera, Inc. (NTRA), a prominent player in the diagnostics and research industry, is capturing significant investor attention as it continues to innovate within the healthcare sector. Headquartered in Austin, Texas,..

Koninklijke Philips N.V. (PHG) Stock Analysis: 22.47% Potential Upside Beckons Investors

For investors seeking opportunities within the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) presents an intriguing proposition. With a market capitalization standing at an impressive $25.71 billion, this Netherlands-based medical..

Pfizer, Inc. (PFE) Stock Analysis: Evaluating a 14.95% Upside Potential Amid Robust Dividend Yields

Pfizer Inc. (NYSE: PFE), a stalwart in the healthcare sector and a cornerstone of the pharmaceutical industry, offers investors an intriguing proposition. With a market capitalization of $142.54 billion, Pfizer’s..

Danaher Corporation (DHR) Stock Analysis: Exploring a 16.91% Potential Upside and Strong Buy Ratings

For investors with a keen eye on the healthcare sector, Danaher Corporation (NYSE: DHR) presents an intriguing opportunity. As a leader in the Diagnostics & Research industry, Danaher boasts a..

Becton, Dickinson and Company (BDX) Stock Analysis: Navigating a 8.83% Potential Upside in Healthcare Innovation

For individual investors looking to delve into the world of healthcare innovation, Becton, Dickinson and Company (NYSE: BDX) presents a compelling opportunity. With a market capitalization of $45.64 billion, BDX..

Novartis AG (NVS) Investor Outlook: Analyzing Market Position Amidst a Strong Dividend Yield and Analyst Ratings

Novartis AG (NYSE: NVS), a global leader in the healthcare sector, stands as a formidable player in the pharmaceutical industry. Based in Switzerland, Novartis is renowned for its robust portfolio..

Haleon plc (HLN) Stock Analysis: With a 19% Potential Upside, Is This Healthcare Giant a Buy?

Haleon plc (HLN), a major player in the healthcare sector, is making waves in the investment community with its promising potential upside of 19.05%. Based in the United Kingdom, this..

Johnson & Johnson (JNJ) Stock Analysis: Here’s Why Investors Are Eyeing a 5.73% Upside

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth metrics. With a market capitalization of..

Medtronic plc (MDT) Stock Analysis: Evaluating a 15% Upside Potential Amidst Robust Revenue Growth

Medtronic plc (NYSE: MDT), a global leader in medical devices, has carved a niche in the healthcare sector with an extensive array of innovative products. Headquartered in Galway, Ireland, Medtronic..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Navigating the Healthcare Giant’s 9.61% Potential Upside

Thermo Fisher Scientific Inc (NYSE: TMO) stands as a powerhouse in the healthcare sector, with a commanding market cap of $213.42 billion. As a leader in the Diagnostics & Research..

Sanofi (SNY) Stock Analysis: 26.77% Potential Upside with Strong Dividend Yield

Sanofi (SNY), a heavyweight in the healthcare sector, is garnering investor attention with an enticing potential upside of 26.77%, alongside a robust dividend yield of 5.61%. With a market capitalization..

UnitedHealth Group (UNH) Stock Analysis: Exploring a 14.68% Upside Potential

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare plans industry, continues to attract investor attention with its formidable market presence and diversified service offerings. With a market capitalization..

Standard BioTools Inc. (LAB) Stock Analysis: Uncovering a 72.74% Upside Potential

As investors seek opportunities in the healthcare sector, Standard BioTools Inc. (NASDAQ: LAB) presents a compelling case with its significant upside potential. With a market capitalization of $351.26 million, this..

AtaiBeckley Inc. (ATAI) Stock Analysis: Navigating Challenges with a Potential 33.53% Upside

AtaiBeckley Inc. (NASDAQ: ATAI) stands as a promising player in the biotechnology sector, focusing its efforts on groundbreaking mental health treatments. With a market capitalization of $2.66 billion, the New..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds